Genetic variant in SWI/SNF complexes influences hepatocellular carcinoma risk: A new clue for the contribution of chromatin remodeling in carcinogenesis

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Zhong, Rong ^a   Liu, Li ^c   Tian, Yao ^b   Wang, Ying ^d   Tian, Jing ^b   Zhu, Bei Bei ^a   Chen, Wei ^a   Qian, Jia Ming ^e,f   Zou, Li ^a   Xiao, Min ^b   Shen, Na ^a   Yang, Hong ^e,f   Lou, Jiao ^a   Qiu, Qian ^b   Ke, Jun Tao ^a   Lu, Xing Hua ^e,f   Wang, Zhen Ling ^a   Song, Wei ^b   Zhang, Ti ^a   Li, Hui ^b   Wang, Li ^b   Miao, Xiao Ping ^a   more..

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^d Wuhan Centers for Disease Prevention and Control   (China)

^e PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^f PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; DNA HELICASE; NONHISTONE PROTEIN; NUCLEAR PROTEIN; SMARCA4 PROTEIN, HUMAN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CASE CONTROL STUDY; CHROMATIN ASSEMBLY AND DISASSEMBLY; FEMALE; GENETIC ASSOCIATION; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA HELICASES; DNA-BINDING PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 84899430918     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04147     Document Type: Article

References (42)

1. Jemal, A. et al. Global cancer statistics. CA. Cancer J. Clin. 61, 69-90 (2011).
2. Hertl, M. & Cosimi, A. B. Liver transplantation for malignancy. Oncologist 10, 269-281 (2005).
3. Nguyen, V. T., Law, M. G. & Dore, G. J. Hepatitis b-related hepatocellular carcinoma: Epidemiological characteristics and disease burden. J. Viral Hepat. 16, 453-463 (2009).
4. Yu, M. C. & Yuan, J. M. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 127, S72-S78 (2004).
5. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA. Cancer J. Clin. 55, 74-108 (2005).
6. Wilson, B. G. & Roberts, C. W. M. Swi/snf nucleosome remodellers and cancer. Nat. Rev. Cancer 11, 481-492 (2011).
7. Li, M. et al. Inactivating mutations of the chromatin remodeling gene arid2 in hepatocellular carcinoma. Nat. Genet. 43, 828-829 (2011).
8. Fujimoto, A. et al.Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. Genet. 44, 760-764 (2012).
9. Huang, J. et al. Exome sequencing of hepatitis b virus-associated hepatocellular carcinoma. Nat. Genet. 44, 1117-1121 (2012).
10. Guichard, C. et al. Integrated analysis of somatic mutations and focal copynumber changes identifies key genes and pathways in hepatocellular carcinoma. Nat. Genet. 44, 694-698 (2012).
11. Varela, I. et al. Exome sequencing identifies frequent mutation of the swi/snf complex gene pbrm1 in renal carcinoma. Nature 469, 539-542 (2011).
12. Biankin, A. V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399-405 (2012).
13. Wang, K. et al. Exome sequencing identifies frequent mutation of arid1a in molecular subtypes of gastric cancer. Nat. Genet. 43, 1219-1223 (2011).
14. Kadoch, C. et al. Proteomic and bioinformatic analysis of mammalian swi/snf complexes identifies extensive roles in human malignancy. Nat. Genet. 45, 592-601 (2013).
15. Jackson, E. M. et al. Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of ini1/smarcb1 in malignant rhabdoid tumors. Clin. Cancer Res. 15, 1923-1930 (2009).
16. Huang, J., Zhao, Y. L., Li, Y., Fletcher, J. A. & Xiao, S. Genomic and functional evidence for an arid1a tumor suppressor role. Gene. Chromosome. Canc. 46, 745-750 (2007).
17. Nagl, N. G., Jr., Wang, X., Patsialou, A., Van Scoy, M. & Moran, E. Distinct mammalian swi/snf chromatin remodeling complexes with opposing roles in cellcycle control. EMBO J. 26, 752-763 (2007).
18. Wong, A. K. et al. Brg1, a component of the swi-snf complex, is mutated in multiple human tumor cell lines. Cancer Res. 60, 6171-6177 (2000).
19. Glaros, S., Cirrincione, G. M., Palanca, A., Metzger, D. & Reisman, D. Targeted knockout of brg1 potentiates lung cancer development. Cancer Res. 68, 3689-3696 (2008).
20. Lee, P. H. & Shatkay, H. F-snp: Computationally predicted functional snps for disease association studies. Nucleic Acids Res. 36, D820-D824 (2007).
21. George Priya Doss, C. et al. Applications of computational algorithm tools to identify functional snps. Funct Integr Genomics 8, 309-316 (2008).
22. Xu, Z. & Taylor, J. A. Snpinfo: Integrating gwas and candidate gene information into functional snp selection for genetic association studies. Nucleic Acids Res. 37, W600-605 (2009).
23. Liang, L. et al.Across-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines. Genome Res. 23, 716-726 (2013).
24. Garraway, L. A. & Lander, E. S. Lessons from the cancer genome. Cell 153, 17-37 (2013).
25. Barker, N. et al. The chromatin remodelling factor brg-1 interacts with betacatenin to promote target gene activation. EMBO J. 20, 4935-4943 (2001).
26. Ho, L. et al. An embryonic stem cell chromatin remodeling complex, esbaf, is an essential component of the core pluripotency transcriptional network. Proc. Natl. Acad. Sci. U. S. A. 106, 5187-5191 (2009).
27. Singh, M., D'Silva, L. & Holak, T. A. DNA-binding properties of the recombinant high-mobility-group-like at-hook-containing region from human brg1 protein. Biol. Chem. 387, 1469-1478 (2006).
28. Shen, W. et al. Solution structure of human brg1 bromodomain and its specific binding to acetylated histone tails. Biochemistry (Mosc). 46, 2100-2110 (2007).
29. Trotter, K. W. & Archer, T. K. The brg1 transcriptional coregulator. Nucl Recept Signal 6, e004 (2008).
30. Dunaief, J. L. et al. The retinoblastoma protein and brg1 form a complex and cooperate to induce cell cycle arrest. Cell 79, 119-130 (1994).
31. Strobeck, M. W. et al. Brg-1 is required for rb-mediated cell cycle arrest. Proc. Natl. Acad. Sci. U. S. A. 97, 7748-7753 (2000).
32. Bultman, S. et al. A brg1 null mutation in the mouse reveals functional differences among mammalian swi/snf complexes. Mol. Cell 6, 1287-1295 (2000).
33. Zhang, H. S. et al. Exit from g1 and s phase of the cell cycle is regulated by repressor complexes containing hdac-rb-hswi/snf and rb-hswi/snf. Cell 101, 79-89 (2000).
34. Naidu, S. R., Love, I. M., Imbalzano, A. N., Grossman, S. R. & Androphy, E. J. The swi/snf chromatin remodeling subunit brg1 is a critical regulator of p53 necessary for proliferation of malignant cells. Oncogene 28, 2492-2501 (2009).
35. Pal, S. et al.Msin3a/histone deacetylase 2- and prmt5-containing brg1 complex is involved in transcriptional repression of the myc target gene cad. Mol. Cell. Biol. 23, 7475-7487 (2003).
36. Kapushesky, M. et al. Gene expression atlas update - a value-added database of microarray and sequencing-based functional genomics experiments. Nucleic Acids Res. 40, D1077-1081 (2012).
37. Middeljans, E. et al. Ss18 together with animal-specific factors defines human baftype swi/snf complexes. PLoS One 7, e33834 (2012).
38. Pan, H. et al. Cellular transcription modulator smarce1 binds to hbv core promoter containing naturally occurring deletions and represses viral replication. Biochim. Biophys. Acta 1772, 1075-1084 (2007).
39. Zhong, R. et al. Genetic variations in the tgfbeta signaling pathway, smoking and risk of colorectal cancer in a chinese population. Carcinogenesis 34, 936-942 (2013).
40. Zhong, R. et al. Genetic variations in tert-clptm1l locus are associated with risk of lung cancer in chinese population. Mol. Carcinog. 52 Suppl 1, E118-126 (2013).
41. Thakkinstian, A. et al. Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: A huge review. Am. J. Epidemiol. 162, 201-211 (2005).
42. Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. & Golani, I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125, 279-284 (2001).